Todos Medical (TOMDF) Osake Kurssi

Todos Medical Kurssi

OTC·SULJETTU
0,00
​
Markkina suljettu

Liikevaihto on kasvanut 21,6 % vuodessa viimeisten 2 vuoden aikana 7,70 M USD:een. Todos Medicaln nettomarginaali on nyt −324,8 %, noussut −571,8 %:sta muutama vuosi sitten.

Todos Medical osakekurssi

Hae nämä tiedot Eulerpool API:n kautta

100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia

Todos Medical liiketoimintamalli ja osakeanalyysi

Todos Medical Ltd on vuonna 2010 perustettu lääketieteellinen yritys. Yrityksen pääkonttori sijaitsee Israelissa, ja sitä johtaa Steve Elms. Todos Medical erikoistuu diagnostiikkatestien ja -laitteiden kehittämiseen ja markkinointiin. Yritys keskittyy tuotteiden kehittämiseen, jotka voivat auttaa yrityksiä ja klinikoita lääketieteellisen diagnostiikan alalla.

Usein kysytyt kysymykset Todos Medical -osakkeesta

The business model of Todos Medical Ltd focuses on providing comprehensive medical solutions, diagnostic tests, and screening services for various health conditions. As a leading healthcare company, Todos Medical aims to identify and develop innovative technologies to improve the detection and management of diseases, including cancer. By offering advanced molecular diagnostic solutions and personalized medicine options, Todos Medical strives to enhance patient outcomes and reduce healthcare costs. With a strong emphasis on cutting-edge research and partnerships with healthcare professionals, the company aims to revolutionize the medical field by offering effective and efficient healthcare solutions.

Todos Medical Ltd is primarily active in the biotech and healthcare industries.

The main competitors of Todos Medical Ltd in the market include companies such as Biocept Inc., Genomic Health Inc., Guardant Health Inc., and Exact Sciences Corporation.

Todos Medical Ltd is a renowned company specializing in medical diagnostics and solutions. Founded in [year], it has emerged as a prominent player in the healthcare industry. Todos Medical Ltd has a rich history of delivering innovative products and services that cater to various medical needs. With a strong focus on research and development, the company has gained recognition for its cutting-edge technologies and reliable diagnostic tools. By continuously expanding its product portfolio and forging strategic partnerships, Todos Medical Ltd has established itself as a trusted name in the market, providing advanced medical solutions worldwide.

Todos Medical Ltd has achieved several significant milestones. The company has successfully developed and commercialized innovative diagnostic solutions, including the proprietary Total Biochemical Infrared Analysis (TBIA) platform. They have made remarkable advancements in cancer screening, with their TBIA-based tests improving detection accuracy and efficiency. Todos Medical has also forged strategic partnerships with leading medical institutions and organizations, expanding their global reach. Additionally, the company has received regulatory approvals for their products, demonstrating their commitment to maintaining high standards in healthcare. These milestones highlight Todos Medical Ltd's dedication to revolutionizing diagnostic capabilities and improving patient outcomes.

Todos Medical Ltd is primarily present in multiple countries and regions worldwide. The company has a global presence, with a focus on several key markets. These include the United States, Israel, Taiwan, and Singapore, amongst others. Todos Medical Ltd strives to expand its reach and market penetration consistently. With a robust international footprint, the company aims to cater to a diverse range of customers and capitalize on emerging business opportunities in different regions. This global presence reinforces Todos Medical Ltd's commitment to delivering innovative solutions and driving growth across various geographical locations.

Todos Medical Ltd represents a set of values and a corporate philosophy centered around innovation, research, and patient care. As a leading biotech company, Todos Medical Ltd is dedicated to delivering advanced diagnostic solutions and personalized medicine to improve healthcare outcomes. With a strong commitment to scientific excellence and technological advancements, the company strives to develop effective and accessible healthcare solutions for different disease areas. By leveraging cutting-edge technologies and collaborations with key industry partners, Todos Medical Ltd is focused on driving innovation and delivering value to patients, healthcare providers, and investors.

Nykyisellä valuuttakurssilla Todos Medical-osake noteerataan hintaan 0,00 EUR (0,00 USD).

Todos Medical Ltd is a biomedical company specializing in the development and marketing of diagnostic and therapeutic solutions for cancer, viral, and bacterial infections. The company was founded in 2010 and is headquartered in Rehovot, Israel. Todos Medical aims to develop groundbreaking technologies and products that contribute to saving lives and improving the quality of life for patients. The business model of Todos Medical is modular and includes several divisions. A key pillar of the business model is the research and development of new diagnostic and therapeutic products. The company has already achieved significant success in this area, including the development of an innovative blood test that allows for rapid and reliable diagnosis of breast, lung, prostate, and colorectal cancer. Another product development is the TolloTest, a PCR test for the determination of COVID-19 and its variants. In addition to product development, Todos Medical also operates a comprehensive marketing and distribution network. The company works with partner firms in various countries and has established its distribution in North America, Europe, and Asia. Through this collaboration, Todos Medical is able to market and distribute its products worldwide. Another important business area of Todos Medical is clinical research and development. The company conducts its own clinical trials and collaborates with renowned institutions such as the University of California, Los Angeles (UCLA) and the Maryland Proton Treatment Center. The goal of clinical research and development is to gather evidence-based data and insights to demonstrate the effectiveness and safety of Todos Medical products. In addition to commercializing its products and conducting clinical research, Todos Medical also provides a range of service and consulting services. The company offers training and education for medical professionals and supports its customers in implementing its products into clinical practice. In summary, the business model of Todos Medical is characterized by a comprehensive product portfolio, a global distribution network, international clinical research and development, and a wide range of consulting and service offerings. Todos Medical is an innovative company driven by the vision of saving lives and improving people's health. With its groundbreaking technologies and products, the company makes a valuable contribution to cancer diagnostics and therapy, as well as the fight against viral and bacterial infections. Answer: Todos Medical Ltd is a biomedical company specializing in the development and marketing of diagnostic and therapeutic solutions for cancer, viral, and bacterial infections.

Liikevaihtoa ei voida laskea Todos Medical:lle tällä hetkellä.

Voittoa ei voida laskea Todos Medical:lle tällä hetkellä.

P/E-suhdetta ei voida laskea Todos Medical:lle tällä hetkellä.

P/S-suhdetta ei voida laskea Todos Medical:lle tällä hetkellä.

Todos Medical:n Eulpool-laatuscore on 3/10.

Todos Medical:n ISIN on IL0011392375. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Todos Medical:n WKN on A2P4UW. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Todos Medical:n ticker on TOMDF. Tämä pörssinoteeraus käytetään Todos Medical-osakkeiden kauppaan pörssissä.

Käypä arvoTerminal
0,00 USD
Yliarviointia/AliarviointiaTerminal
Reilusti arvostettu
Sektori
—
Toimiala
Muu
Osakkeiden lukumäärä
Työntekijät
Liikevaihto per työntekijä
1,92 M USD
Liikevaihdon kasvu Ø 5 vuotta
EBIT-kasvu Ø 5 vuotta
Nettotulon kasvu Ø 5 vuotta
Verkkosivusto todosmedical.com
Maa
Israel
Valuutta
USD
Julkinen listaus
21.2.2017
ISIN
IL0011392375
CUSIP
M8790Y108
SEDOL
BF0SR30
Markkina-arvo
52 viikon vaihteluväli
PEG-suhde
—
P/E-suhde
P/Ee-suhde
—
P/S-suhde
P/Se-suhde
—
EV/EBIT
—
P/B-suhde
—
ROE (oman pääoman tuotto)
ROA (varojen tuotto)
ROCE (pääomakäytön tuotto)
ROIC (sijoitetun pääoman tuotto)
−881,31 %
Viimeksi päivitetty 28.10.2026 klo 23.00

Todos Medical vertaisryhmä

Todos Medical Ticker

OTC · TOMDFOTC · TOMDF

Todos Medical FIGI

TOMDF:US · BBG00CLFS6F6TOMDF:PQ · BBG00CLFS719TOMDF:UV · BBG00CLFS728

Kaikki tunnusluvut ja syvällinen analyysi Todos Medical:sta

Meidän osakeanalyysimme Todos Medical-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Todos Medical:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: